Loading…
Cingulate Inc. is projected to decline to $4.77 by 2027, a 0% move from its current price of $4.79. CING is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.62 | $4.79 | $4.96 | -0.10% |
| Aug 6 | $4.55 | $4.78 | $5.02 | -0.19% |
| Aug 7 | $4.50 | $4.78 | $5.08 | -0.29% |
| Aug 8 | $4.45 | $4.77 | $5.12 | -0.38% |
| Aug 9 | $4.41 | $4.77 | $5.16 | -0.48% |
| Aug 10 | $4.37 | $4.76 | $5.19 | -0.57% |
| Aug 11 | $4.34 | $4.76 | $5.22 | -0.66% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.34 | $4.76 | $5.22 | -0.66% |
| Week 2 | $4.15 | $4.73 | $5.39 | -1.32% |
| Week 3 | $4.00 | $4.70 | $5.51 | -1.98% |
| Week 4 | $3.87 | $4.66 | $5.61 | -2.63% |
| Week 5 | $3.77 | $4.63 | $5.70 | -3.28% |
| Week 6 | $3.67 | $4.60 | $5.78 | -3.92% |
| Week 7 | $3.58 | $4.57 | $5.84 | -4.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
Its lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD.
Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Cingulate Inc. (CING) is a healthcare company whose stock trades at $4.78 per share and carries a market capitalization of $64.31M. It ranks 4399 in market capitalization among public companies.
The asset operates in the healthcare sector and provides a price outlook based on multi-year forecasts that project upside over time. The forecast shows bullish potential in the long run, with 2050 average prices rising to $18.31 and an estimated ROI of 283.4.
Near-term technicals are mixed, with a 30-day range of $3.64 to $6.27 and structured around key moving averages. The SMA50 is $4.76 and the SMA200 is $5.07, with support at $4.43 and resistance at $5.89.
Trading activity includes an annualized volatility metric of 80 and a current neutral technical tone, guiding a cautious but upward-skewed outlook over time.
A major floor 25.3% below — a decisive break under it would weaken the trend.
The nearest floor, 7.5% below — buyers have tended to step in here.
The nearest ceiling, 23.0% above — a clean break opens room to run.
A major ceiling 40.1% above — clearing it would confirm fresh momentum.
Key CING support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CING market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.63 | Buy | $4.69 | Buy |
| MA 10 | $4.68 | Buy | $4.69 | Buy |
| MA 20 | $4.74 | Buy | $4.74 | Buy |
| MA 50 | $4.76 | Buy | $4.88 | Sell |
| MA 100 | $5.43 | Sell | $5.06 | Sell |
| MA 200 | $5.09 | Sell | $5.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.58 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 19.39 | Neutral |
| Williams %R (14) | -12.20 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 4.36 | Buy |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 87.80 | Sell |
| TRIX (15) | -0.20 | Sell |
| Awesome (5,34) | -0.25 | Sell |
| Ultimate (7,14,28) | 48.55 | Neutral |
| Momentum (10) | 0.25 | Buy |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 4.64 | Buy |
| ADX (14) | 8.53 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) is 50, and the stock trades near the SMA50 of $4.76. The SMA200 sits at $5.07, offering resistance above the near-term price.
Support is identified at $4.43 and resistance at $5.89, framing a 30-day price range from $3.64 to $6.27. The asset also shows an annualized volatility of 80, indicating notable variability in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.60 | $4.79 | $5.93 | 0% | Neutral | |
| $3.71 | $4.77 | $6.55 | 0% | Neutral | |
| $4.01 | $5.36 | $7.70 | +12% | Neutral | |
| $4.40 | $6.06 | $9.03 | +27% | Bullish | |
| $4.75 | $6.73 | $10.33 | +40% | Bullish | |
| $4.69 | $6.82 | $10.75 | +42% | Bullish | |
| $4.50 | $6.69 | $10.79 | +40% | Bullish | |
| $4.21 | $6.40 | $10.54 | +34% | Bullish | |
| $4.14 | $6.44 | $10.80 | +34% | Bullish | |
| $5.17 | $8.21 | $14.02 | +71% | Bullish | |
| $5.32 | $9.27 | $17.05 | +94% | Bullish | |
| $9.45 | $19.53 | $39.89 | +308% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.60 | $4.79 | $5.82 | +0.00% |
| September 2026 | $3.83 | $4.57 | $5.63 | -4.65% |
| October 2026 | $3.65 | $4.39 | $5.48 | -3.85% |
| November 2026 | $3.76 | $4.55 | $5.75 | +3.68% |
| December 2026 | $3.81 | $4.65 | $5.93 | +2.20% |
Click any year to see its month-by-month CING forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cingulate Inc.'s 2026 outlook centres on $4.79, within a $3.60 to $5.93 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CING could reach as high as $6.55, with a base case around $4.77 and support toward $3.71 — roughly 0% from $4.79. A consolidation phase looks the most probable path here.
Expect CING to range from $4.01 to $7.70 through 2028. The $5.36 average target implies a +12% move from current prices. That is up +12% on the projected 2027 average. Price action looks broadly range-bound.
The CING price prediction for 2029 points to an average of $6.06 (low $4.40, high $9.03) — a potential gain of +27% on today's $4.79. Buyers look set to stay in control over this stretch.
In 2030, CING is projected to trade between $4.75 and $10.33, averaging $6.73 — a potential gain of +40% from today's $4.79. That is up +11% on the projected 2029 average. Momentum favours further upside here.
Cingulate Inc.'s 2031 outlook centres on $6.82, within a $4.69 to $10.75 range. That is up +1% on the projected 2030 average. That marks a +42% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CING could reach as high as $10.79, with a base case around $6.69 and support toward $4.50 — roughly +40% from $4.79. Momentum favours further upside here.
Expect CING to range from $4.21 to $10.54 through 2033. The $6.40 average target implies a +34% move from current prices. That is -4% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The CING price prediction for 2034 points to an average of $6.44 (low $4.14, high $10.80) — a potential gain of +34% on today's $4.79. Momentum favours further upside here.
In 2035, CING is projected to trade between $5.17 and $14.02, averaging $8.21 — a potential gain of +71% from today's $4.79. That is up +28% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Cingulate Inc.'s 2040 outlook centres on $9.27, within a $5.32 to $17.05 range. That is up +13% on the projected 2035 average. That marks a +94% change versus current levels. Momentum favours further upside here.
By 2050, CING could reach as high as $39.89, with a base case around $19.53 and support toward $9.45 — roughly +308% from $4.79. Buyers look set to stay in control over this stretch.
Investing $1,000 in CING today (≈ 208.768267 CING) could be worth
$4,077.46
+$3,077.46 (+308%) by 2050 · US Dollar
Based on the average projected CING price of $19.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CINGwould be worth at today's price.
$1,000 invested in CING on Jul 31, 2025 (≈ 193.050199 CING) would be worth
$924.71
-$75.29 (-7.5%) today · 0.92× · US Dollar
Based on a CING entry price of $5.18 vs. today's $4.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.64 | $1,032.33 | +3.2% |
| 1 month ago | $5.89 | $813.24 | -18.7% |
| 3 months ago | $5.37 | $891.99 | -10.8% |
| 6 months ago | $6.11 | $783.96 | -21.6% |
| 1 year ago | $5.18 | $924.71 | -7.5% |
| All time (4.6y) ago | $1,068 | $4.49 | -99.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CING forecast.
Our base-case forecast reaches $9.60 around 2050.
Implied market cap at $9.60: $129.3M
The multi-year forecast projects a bullish trajectory from 2029 onward, with 2030 averaging $6.67 and a ROI of 39.7. The 2040 forecast shows an average of $8.61 and a ROI of 80.3, while 2050 is expected to average $18.31 with a ROI of 283.4.
The sentiment shifts to BULLISH in 2029 and remains so in later years, with progressively higher average prices in years such as 2031 ($6.82 average) and 2035 ($7.66 average) among others. These figures illustrate a long-term upside potential, though they are estimates and not guarantees.
Investors should consider that forecasts are subject to uncertainty and not guarantees of future performance.
Tap a question to reveal the answer.
2030 forecast: min $4.51, avg $6.67, max $10.70; ROI 39.7; sentiment BULLISH.
Long-term forecasts imply a bullish sentiment from 2029 onward, with 2050 avg $18.31 and ROI 283.4, but these are estimates and not guarantees.
Yes. The 2031 forecast lists max $11.27, and the 2030 forecast lists max $10.70.
The current price is $4.78.
Sentiment is NEUTRAL; RSI14 is 50; SMA50 is $4.76; SMA200 is $5.07; support $4.43; resistance $5.89; 30-day range $3.64 to $6.27; annualized volatility 80.
Cingulate Inc. Community Discussion
0Share your Cingulate Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.